Alloy Women's Health vs Midi Health
Both are built for women in perimenopause and menopause, and both employ clinicians trained for that population. The practical difference is that Alloy charges a $99/month membership and offers the broadest medication catalogue we found, while Midi charges no membership and sources from 503B-accredited pharmacies.
Last updated August 5, 2026
Side by side
| Dimension | Alloy Women's Health | Midi Health |
|---|---|---|
| Membership fee | $99/month Alloy Weight Care | None |
| Cheapest compounded semaglutide | From $70/month (plus $99 membership ≈ $169 all in) | $165.90 per 4-week supply at the lowest dose |
| Brand-name options | Zepbound $299, Wegovy pen $199, Wegovy pill $149, Foundayo $149 | Prescription sent to your pharmacy of choice |
| Pharmacy sourcing | Not disclosed for compounded products | Stated 503B-accredited |
| Non-injectable options | Wegovy pill and Foundayo (both FDA-approved orals) | Compounded sublingual GLP-1 and GLP-1/GIP |
| Price transparency | Starting prices published per product | Full dose-by-dose table published |
| State restrictions | Compounded unavailable in AL, AR, CA, NV, LA, MS and DC | Not published |
| Insurance | FAQ present but unanswered on the weight page | Insurance-covered visits for qualifying patients |
| Clinician specialisation | Menopause-trained physicians | Midlife women's health clinicians |
| Turnaround | Treatment plan in under 12 hours | Booked visits with clinicians |
Highlighted cells indicate the stronger position on that dimension only. Facts are taken from each provider's own published materials and are recorded in full on their individual review pages.
Choose Alloy Women's Health if…
- You want the widest choice of GLP-1s including brand-name and the new oral options
- You want the fastest path from intake to a treatment plan
- You want to move between compounded and brand-name on one platform
- You want published state exclusions before you start
Choose Midi Health if…
- You do not want a $99/month membership on top of medication
- You want 503B-accredited pharmacy sourcing
- You want a sublingual option rather than an injection
- You may qualify for insurance-covered visits
Our verdict
Midi is the better structural deal — no membership, a full published price table, 503B sourcing that beats most compounded competitors on regulatory footing, and insurance-covered visits for qualifying patients. Alloy is the better catalogue: brand-name Zepbound at $299, the Wegovy pen and pill, and Foundayo alongside three compounded options, all prescribed by menopause-trained physicians, with a treatment plan inside 12 hours. If you specifically want brand-name or oral FDA-approved medication and value speed, Alloy justifies its membership. If you want compounded therapy at the lowest true cost with better pharmacy disclosure, Midi wins.
Frequently asked questions
Is Alloy's $70 semaglutide really the cheapest?
It is the lowest medication line item we found, but not the lowest total cost — the $99/month Alloy Weight Care membership applies on top, making the real figure around $169/month. Providers with no membership fee, like Cora Health at $99 all-inclusive, come out lower.
Does either offer the new oral GLP-1 pill?
Alloy does — it lists both the Wegovy Pill and Foundayo (orforglipron) starting at $149 plus membership. Midi's non-injectable options are compounded sublingual formulations, which are not FDA-approved and have not been studied to the same standard.
Compare more options
Medical disclaimer
This comparison is for informational purposes only and is not medical advice, a diagnosis, or a treatment recommendation. Only a licensed clinician who has evaluated you can decide whether any medication is appropriate. Pricing, medication availability, pharmacy partners and policies change frequently and vary by state — verify everything directly with the provider before purchasing.